Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381194180> ?p ?o ?g. }
- W4381194180 endingPage "115572" @default.
- W4381194180 startingPage "115572" @default.
- W4381194180 abstract "The Togaviridae family comprises several New- and Old-World Alphaviruses that have been responsible for thousands of human illnesses, including the RNA arbovirus Chikungunya virus (CHIKV). Firstly, it was reported in Tanzania in 1952 but rapidly it spread to several countries from Europe, Asia, and the Americas. Since then, CHIKV has been circulating in diverse countries around the world, leading to increased morbidity rates. Currently, there are no FDA-approved drugs or licensed vaccines to specifically treat CHIKV infections. Thus, there is a lack of alternatives to fight against this viral disease, making it an unmet need. Structurally, CHIKV is composed of five structural proteins (E3, E2, E1, C, and 6k) and four non-structural proteins (nsP1-4), in which nsP2 represents an attractive antiviral target for designing novel inhibitors since it has an essential role in the virus replication and transcription. Herein, we used a rational drug design strategy to select some acrylamide derivatives to be synthesized and evaluated against CHIKV nsP2 and also screened on CHIKV-infected cells. Thus, two regions of modifications were considered for these types of inhibitors, based on a previous study of our group, generating 1560 possible inhibitors. Then, the 24 most promising ones were synthesized and screened by using a FRET-based enzymatic assay protocol targeting CHIKV nsP2, identifying LQM330, 333, 336, and 338 as the most potent inhibitors, with Ki values of 48.6 ± 2.8, 92.3 ± 1.4, 2.3 ± 1.5, and 181.8 ± 2.5 μM, respectively. Still, their Km and Vmax kinetic parameters were also determined, along with their competitive binding modes of CHIKV nsP2 inhibition. Then, ITC analyses revealed KD values of 127, 159, 198, and 218 μM for LQM330, 333, 336, and 338, respectively. Also, their ΔH, ΔS, and ΔG physicochemical parameters were determined. MD simulations demonstrated that these inhibitors present a stable binding mode with nsP2, interacting with important residues of this protease, according to docking analyzes. Moreover, MM/PBSA calculations displayed that van der Waals interactions are mainly responsible for stabilizing the inhibitor-nsP2 complex, and their binding energies corroborated with their Ki values, having −198.7 ± 15.68, −124.8 ± 17.27, −247.4 ± 23.78, and −100.6 ± 19.21 kcal/mol for LQM330, 333, 336, and 338, respectively. Since Sindbis (SINV) nsP2 is similar to CHIKV nsP2, these best inhibitors were screened against SINV-infected cells, and it was verified that LQM330 presented the best result, with an EC50 value of 0.95 ± 0.09 μM. Even at 50 μM concentration, LQM338 was found to be cytotoxic on Vero cells after 48 h. Then, LQM330, 333, and 336 were evaluated against CHIKV-infected cells in antiviral assays, in which LQM330 was found to be the most promising antiviral candidate in this study, exhibiting an EC50 value of 5.2 ± 0.52 μM and SI of 31.78. The intracellular flow cytometry demonstrated that LQM330 is able to reduce the CHIKV cytopathogenic effect on cells, and also reduce the percentage of CHIKV-positive cells from 66.1% ± 7.05–35.8% ± 5.78 at 50 μM concentration. Finally, qPCR studies demonstrated that LQM330 was capable of reducing the number of viral RNA copies/μL, suggesting that CHIKV nsP2 is targeted by this inhibitor as its mechanism of action." @default.
- W4381194180 created "2023-06-20" @default.
- W4381194180 creator A5015618740 @default.
- W4381194180 creator A5016068613 @default.
- W4381194180 creator A5019101557 @default.
- W4381194180 creator A5038019453 @default.
- W4381194180 creator A5043089740 @default.
- W4381194180 creator A5053043921 @default.
- W4381194180 creator A5061976441 @default.
- W4381194180 creator A5073599539 @default.
- W4381194180 creator A5073848646 @default.
- W4381194180 creator A5078027509 @default.
- W4381194180 creator A5080295191 @default.
- W4381194180 creator A5082048954 @default.
- W4381194180 creator A5092203555 @default.
- W4381194180 date "2023-10-01" @default.
- W4381194180 modified "2023-10-16" @default.
- W4381194180 title "Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus" @default.
- W4381194180 cites W1182581869 @default.
- W4381194180 cites W1544578140 @default.
- W4381194180 cites W1968984443 @default.
- W4381194180 cites W1976218846 @default.
- W4381194180 cites W1981021420 @default.
- W4381194180 cites W1986191025 @default.
- W4381194180 cites W1994344551 @default.
- W4381194180 cites W2000037127 @default.
- W4381194180 cites W2001702281 @default.
- W4381194180 cites W2002064064 @default.
- W4381194180 cites W2003076573 @default.
- W4381194180 cites W2004516303 @default.
- W4381194180 cites W2010031236 @default.
- W4381194180 cites W2010464955 @default.
- W4381194180 cites W2011505858 @default.
- W4381194180 cites W2026106662 @default.
- W4381194180 cites W2033353435 @default.
- W4381194180 cites W2041791898 @default.
- W4381194180 cites W2043509228 @default.
- W4381194180 cites W2048072131 @default.
- W4381194180 cites W2048214699 @default.
- W4381194180 cites W2050456292 @default.
- W4381194180 cites W2052907531 @default.
- W4381194180 cites W2053684277 @default.
- W4381194180 cites W2062323422 @default.
- W4381194180 cites W2064777369 @default.
- W4381194180 cites W2082210558 @default.
- W4381194180 cites W2082627744 @default.
- W4381194180 cites W2085663480 @default.
- W4381194180 cites W2095719702 @default.
- W4381194180 cites W2100643644 @default.
- W4381194180 cites W2105649494 @default.
- W4381194180 cites W2105668062 @default.
- W4381194180 cites W2111280136 @default.
- W4381194180 cites W2114135904 @default.
- W4381194180 cites W2116698685 @default.
- W4381194180 cites W2137576308 @default.
- W4381194180 cites W2144288821 @default.
- W4381194180 cites W2144994958 @default.
- W4381194180 cites W2147993766 @default.
- W4381194180 cites W2161605421 @default.
- W4381194180 cites W2166344128 @default.
- W4381194180 cites W2167854315 @default.
- W4381194180 cites W2168130018 @default.
- W4381194180 cites W2332896222 @default.
- W4381194180 cites W2411577186 @default.
- W4381194180 cites W2435566767 @default.
- W4381194180 cites W2515573625 @default.
- W4381194180 cites W2531207559 @default.
- W4381194180 cites W2535671261 @default.
- W4381194180 cites W2552792269 @default.
- W4381194180 cites W2564708666 @default.
- W4381194180 cites W2577558456 @default.
- W4381194180 cites W2593436234 @default.
- W4381194180 cites W2597209991 @default.
- W4381194180 cites W2604343314 @default.
- W4381194180 cites W2605266135 @default.
- W4381194180 cites W2606142660 @default.
- W4381194180 cites W2616380620 @default.
- W4381194180 cites W2731849689 @default.
- W4381194180 cites W2745929918 @default.
- W4381194180 cites W2748072911 @default.
- W4381194180 cites W2774836366 @default.
- W4381194180 cites W2781601865 @default.
- W4381194180 cites W2781651822 @default.
- W4381194180 cites W2790562579 @default.
- W4381194180 cites W2793762043 @default.
- W4381194180 cites W2795865539 @default.
- W4381194180 cites W2799448238 @default.
- W4381194180 cites W2811099456 @default.
- W4381194180 cites W2857483486 @default.
- W4381194180 cites W2883308915 @default.
- W4381194180 cites W2897683782 @default.
- W4381194180 cites W2897915910 @default.
- W4381194180 cites W2898437056 @default.
- W4381194180 cites W2903893039 @default.
- W4381194180 cites W2921008607 @default.
- W4381194180 cites W2922043794 @default.
- W4381194180 cites W2939105285 @default.
- W4381194180 cites W2947920041 @default.